With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.

Combining two of the most established iPSC conferences, iPSC-Derived Cell Therapies and iPSC Manufacturing, into a single flagship event, the 4th iPSC Drug Development & Manufacturing Summit will showcase cutting-edge advances across R&D through to manufacturing and analytical development to help you stay at the forefront of the iPSC cell therapy revolution.

With content split across our Research & Development and Manufacturing & Analytical Development tracks, this is the one-stop shop meeting for drug developers and academic thought leaders looking to streamline their route to the clinic and scale up their manufacturing processes.

Event Link here.